4CPS-339 Intrathecal administration of baclofen for the reduction of spasticity

I Barbato, B Esposito, MR Miranda, A D'avino, L Columbano, M Spatarella
2021 Section 4: Clinical pharmacy services   unpublished
therapy. In addition, it was prescribed in patients with a higher D-dimer. Doses and number of administrations were higher in the first peak. New scientific evidence led to the use of different concomitant treatments in the second peak: corticosteroids (second peak dexamethasone versus first peak methylprednisolone) and antiviral therapy (only remdesivir in the second peak). In the second peak, hospital and ICU stays were shorter, probably because tocilizumab was used in less serious patients.
more » ... espite this, no differences in mortality were observed. A study limitation was sample size.
doi:10.1136/ejhpharm-2021-eahpconf.171 fatcat:lu332zjphvh5bhokcpxd4t64x4